Navneet Matharu

Navneet Matharu serves as Chief Scientific Officer at Regel Tx since January 2021 and as a WIES Fellow and Principal Investigator at the Innovative Genomics Institute since May 2019. Additionally, Navneet holds the position of Assistant Professor at the University of California, San Francisco since January 2019 and is also the Founder and CSO of Regel Therapeutics since October 2020. Prior experience includes serving as a Postdoctoral Fellow at UCSF from July 2013 to July 2018. Navneet Matharu specializes in CRISPR, genomics, gene regulation, and genetic diseases.